We investigated the relation between genomic heterogeneity and FAM72B gene expression in pan-cancer from the perspectives of TMB and NEO, with the aim of identifying appropriate immunotherapies for the prognosis of cancer patients [53,54,55]. Here, FAM72B is linked to cancer.